Coprococcus sp.

Information

Microbe Identification

Coprococcus sp.

Microbe id: PMDBM2021499
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Coprococcus sp. [2049024]
Taxonomy Genus: Coprococcus [33042]
Taxonomy Family: Lachnospiraceae [186803]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Coprococcus sp.

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Coprococcus sp.


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Coprococcus sp. distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Coprococcus sp. in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Coprococcus sp.

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA449784🔗-3.91728524214353mNGS
Kidney Failure, Chronic PRJNA648014🔗-3.4710079040707916S
Kidney Failure, Chronic PRJEB65297🔗-3.30690727955558mNGS
Hemangioma, Cavernous PRJNA629755🔗-4.17129755829253mNGS
Hypertension PRJNA509999🔗-3.92264254085223mNGS
Diabetes Mellitus, Type 2 PRJNA871997🔗-3.9011020472982816S
Liver Cirrhosis, Alcoholic PRJNA690835🔗-4.2230964835012516S
Diarrhea PRJEB14038🔗-4.25805736623053mNGS
Diarrhea PRJNA317326🔗-3.8952610461191416S
Dwarfism PRJNA819198🔗-3.4382359616428616S
Colorectal Neoplasms PRJNA1167935🔗-4.10589867664465mNGS
Colorectal Neoplasms PRJNA731589🔗-4.10169050927981mNGS
Colorectal Neoplasms PRJNA888860🔗-3.97889833595094mNGS
Colorectal Neoplasms PRJNA1138893🔗-3.95913079090112mNGS
Colorectal Neoplasms PRJEB53891🔗-3.89660306587211mNGS
Colorectal Neoplasms PRJEB46665🔗-3.8123720227556916S
Colorectal Neoplasms PRJEB53415🔗3.5258043471041716S
Colorectal Neoplasms PRJNA936589🔗4.14872523379337mNGS
Lupus Erythematosus, Systemic PRJEB52971🔗-3.9301456451563616S
Diabetes Mellitus, Type 1 PRJNA604850🔗-3.62667794019203mNGS
Parkinson Disease PRJNA742875🔗-3.9404633254195216S
Parkinson Disease PRJNA626004🔗4.13249557191076mNGS
Colitis, Ulcerative PRJEB42155🔗-4.35452552301763mNGS
Colitis, Ulcerative PRJNA804422🔗-3.7204889252831316S
Colitis, Ulcerative PRJNA993675🔗-3.69680736061207mNGS
Colitis, Ulcerative PRJNA398089🔗-3.13548309298982mNGS
Colitis, Ulcerative PRJNA983946🔗-3.09634679933521mNGS
Campylobacter Infections PRJNA660443🔗-3.3335859060667mNGS
Spinal Cord Injuries PRJNA861246🔗-3.6378102532139416S
Spinal Cord Injuries PRJNA669472🔗-3.5159498888897116S
Macular Degeneration PRJEB13835🔗3.54297336416966mNGS
Carcinoma, Hepatocellular PRJNA932948🔗-3.91640022690282mNGS
Helicobacter Infections PRJDB10599🔗3.4376529146209616S
Spondylarthritis PRJNA342486🔗-3.8558640754441716S
Caliciviridae Infections PRJNA788674🔗-3.7316096552113116S
Osteoporosis PRJNA565497🔗2.6544359237917916S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-3.1045771086938516S
Non-alcoholic Fatty Liver Disease PRJNA851946🔗-3.8702747232838516S
Hidradenitis Suppurativa PRJEB43835🔗-4.2655853312027116S
Leukemia, Myeloid, Acute PRJNA813705🔗-4.13122652792996mNGS
Tic Disorders PRJNA780788🔗-3.8453624533781216S
Crohn Disease PRJEB42155🔗-4.31889922964069mNGS
Crohn Disease PRJNA813736🔗-4.22128699986078mNGS
Crohn Disease PRJNA909073🔗-4.1273382358354216S
Crohn Disease PRJNA938107🔗-4.0990800154778916S
Crohn Disease PRJNA793776🔗-4.04899758963544mNGS
Crohn Disease PRJEB76677🔗-3.96761034025667mNGS
Crohn Disease PRJNA917086🔗-3.6927683180467816S
Crohn Disease PRJNA993675🔗-3.56888228534314mNGS
Crohn Disease PRJNA429990🔗-3.53352965080385mNGS
Crohn Disease PRJNA398089🔗-3.48001642986053mNGS
Psoriasis PRJNA634145🔗-4.3677559018347mNGS
Polycystic Ovary Syndrome PRJNA530971🔗-4.28204987392809mNGS
Moyamoya Disease PRJNA917033🔗-3.8957733188346116S
Arthritis, Rheumatoid PRJNA786110🔗-4.0071274602662316S
Arthritis, Rheumatoid PRJNA896336🔗4.36316963291126mNGS
Fatigue Syndrome, Chronic PRJNA379741🔗-3.76796352805238mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗-3.75403545014355mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗-3.36792844227482mNGS
Anorexia PRJNA674716🔗-3.54688344903531mNGS
Autoimmune Diseases of the Nervous System PRJNA586763🔗4.4870899375285116S
Nephrotic Syndrome PRJNA800189🔗-4.1819798904919516S
Neuroblastoma PRJEB63351🔗-3.8857459977535mNGS
Hematologic Neoplasms PRJNA777832🔗-3.8593777189998816S
Irritable Bowel Syndrome PRJEB37924🔗-4.14666507390989mNGS
Epilepsy PRJNA506309🔗-4.3066593424273516S
Clostridium Infections PRJNA648321🔗-3.88952913464132mNGS
Pancreatic Neoplasms PRJNA665854🔗-4.13269167526431mNGS
Alzheimer Disease PRJEB51982🔗-4.0811755817476616S
Liver Cirrhosis PRJNA861246🔗-3.5983844004017316S
Anti-N-Methyl-D-Aspartate Receptor Encephalitis PRJNA764676🔗-3.9264743128160216S
Obesity PRJNA1125836🔗3.73718318960533mNGS
Diabetes Mellitus PRJNA774037🔗4.0661928777051816S
Diabetes Mellitus PRJNA400325🔗4.1477212201487816S
HIV Infections PRJNA810567🔗-3.9495457930466916S
Inflammatory Bowel Diseases PRJNA511372🔗-4.16100998422446mNGS
Inflammatory Bowel Diseases PRJNA1028828🔗-3.9962898780489316S
Inflammatory Bowel Diseases PRJEB13266🔗-3.9511748009304816S
Renal Insufficiency, Chronic PRJNA562327🔗-3.8486203355349616S
Renal Insufficiency, Chronic PRJEB34855🔗-3.6993170217731116S
Renal Insufficiency, Chronic PRJNA659589🔗-3.4095659591730116S
Multiple Sclerosis PRJEB34168🔗-3.7607213086035216S
Fibromyalgia PRJEB80379🔗-4.20192985881596mNGS
Breast Neoplasms PRJNA658160🔗-3.6454724340058516S
COVID-19 PRJNA769052🔗-3.9516579099677516S
COVID-19 PRJNA624223🔗-3.94906743495699mNGS
COVID-19 PRJNA678695🔗-3.8531267474063416S
COVID-19 PRJNA689961🔗-3.74642731798387mNGS
COVID-19 PRJDB13214🔗-3.60097577795708mNGS
COVID-19 PRJNA907010🔗3.7974901178181916S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Coprococcus sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Coprococcus sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Coprococcus sp.

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Coprococcus sp.


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Coprococcus sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Coprococcus sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Coprococcus sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Coprococcus sp.

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Coprococcus sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Coprococcus sp.


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Coprococcus sp.


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?